We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of ACUR yet.

ACUR Hedge Fund Activity: Q3 2021 in Review

2 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q3 2021, worth a combined $0 — down 100% from $1K a quarter earlier.

Fund positioning in ACUR was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 2 institutional investors held Acura Pharmaceuticals (ACUR) as of Q3 2021, unchanged from Q2 2021.
  • Funds reported $0 of Acura Pharmaceuticals stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Acura Pharmaceuticals positions in Q3 2021 and 0 closed out.

Based on aggregated 13F filings for Q3 2021.